Opportunity for advanced injectable drug delivery
Evaluating market potential and growth opportunities for advanced injectable drug delivery in India and Bangladesh, with focus on export-oriented pharmaceutical companies.
Overview: This study focuses on evaluating the Advanced Drug Delivery Systems (ADDS) market potential in India and Bangladesh, emphasizing export-oriented pharmaceutical companies' needs. It projects market size and assesses industry requirements over a 5- to 10-year horizon.
Context: The client, a leading medical technology company, sought a robust understanding of ADDS market opportunities and challenges to support strategic positioning and growth in both domestic and export markets.
Approach: Extensive primary research included interviews with 54 key industry stakeholders such as pharmaceutical companies, ADDS specialists, Contract Development and Manufacturing Organizations (CDMOs), healthcare consultants, and competitors.
Insights: The study provided market size projections for 2025 and 2030, segmented market estimates, demand-supply driver analysis, competitor benchmarking, and collaboration ecosystem mapping. Notably, it identified capability gaps shaping future development and growth potential for ADDS.